Response to commentaries on 'Alpha calculus in clinical trials: considerations for the new millennium'
Stat Med
.
2000 Mar 30;19(6):795-9.
doi: 10.1002/(sici)1097-0258(20000330)19:6<795::aid-sim521>3.0.co;2-g.
Author
LA Moye
PMID:
10734283
DOI:
10.1002/(sici)1097-0258(20000330)19:6<795::aid-sim521>3.0.co;2-g
No abstract available